Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
With a market cap of 8.81B, Corcept Therapeutics(CORT) trades at $83.76. The stock has a price-to-earnings ratio of 95.70.
On 2025-12-20, Corcept Therapeutics(CORT) stock traded between a low of $81.26 and a high of $85.34. Shares are currently priced at $83.76, which is +3.1% above the low and -1.9% below the high.
The Corcept Therapeutics(CORT)'s current trading volume is 2.11M, compared to an average daily volume of 1.09M.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
During the past year, Corcept Therapeutics(CORT) stock moved between $49.00 at its lowest and $117.33 at its peak.
CORT News
Corcept Therapeutics (CORT) is down -8.5%, or -$7.40 to $79.90. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and pow...
Ashwani Verma, an analyst from UBS, has initiated a new Hold rating on Corcept Therapeutics (CORT). Claim 50% Off TipRanks Premium and Invest with Confidence Un...